24/7 Market News Snapshot 29 May, 2025 – Taysha Gene Therapies, Inc. Common Stock (NASDAQ:TSHA)

May 29, 2025

DENVER, Colo., 29 May, 2025 (www.247marketnews.com) – (Nasdaq:TSHA) are discussed in this article.
Taysha Gene Therapies, Inc. (Nasdaq:TSHA), a leader in the development of adeno-associated virus (AAV)-based gene therapies, is witnessing heightened investor interest following a notable performance in the stock market. The company’s shares opened at $2.85 and currently trade at approximately $2.905, reflecting a formidable increase of about 19.06% from the previous closing price of $2.44. With a trading volume of 5.89 million shares, there is a strong bullish sentiment surrounding the stock, leading traders to observe key support levels around $2.85 and resistance points near recently established highs.

Simultaneously, Taysha has initiated an underwritten public offering aimed at raising approximately $200 million, through the sale of 46,868,687 shares of common stock priced at $2.75 each. Additionally, pre-funded warrants offering 25,858,586 shares are available at a price of $2.749 each. Investors will also have the opportunity to purchase up to an additional 10,909,090 shares, should the underwriters exercise their 30-day option.

The expected closing of this offering is anticipated around May 30, 2025, subject to customary closing conditions. The capital raised will further enhance Taysha’s pipeline focused on innovative gene therapies that address severe monogenic diseases impacting the central nervous system. Notably, the lead clinical program, TSHA-102, targets Rett syndrome, a rare neurodevelopmental disorder lacking approved therapeutic options that tackle its genetic basis.

This strategic financial maneuver underscores Taysha’s ongoing commitment to revolutionizing patient care through advanced gene therapy solutions. The company’s management, with extensive experience in the field, seeks to deliver transformative treatments to underserved patient populations, further solidifying its position in the biotechnology sector.

Related news for (TSHA)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.